Acne in Patients with Skin of Color: Practical Management

  title={Acne in Patients with Skin of Color: Practical Management},
  author={Natalie C. Yin and Amy J. McMichael},
  journal={American Journal of Clinical Dermatology},
  • N. YinA. McMichael
  • Published 1 February 2014
  • Medicine
  • American Journal of Clinical Dermatology
Acne vulgaris is a prevalent and non-discriminatory condition affecting individuals of all races and ethnicities. As people with skin of color make up a rapidly expanding segment of the US population, dermatologic care must evolve accordingly to address their distinct concerns. Patients with skin of color with acne can be particularly challenging, given their potential for cosmetically disturbing complications, including post-inflammatory hyperpigmentation and keloid development. A variety of… 

Dermatology: how to manage acne in skin of colour

Overall, based on limited evidence, topical and systemic therapies are well tolerated in the SOC population but efficacy should be balanced with the risk of adverse effects.

Acne on pigmented skin

In order to improve tolerability and compliance of topical anti-acne therapy in patients with pigmented skin, it is helpful to begin the treatment with the lowest concentration of the drug, to use a cream or an aqueous gel as vehicle, to apply the drug every other day, with gradual increase to daily use, and to apply frequently a moisturizer.

Management of Acne Vulgaris: A Review.

Isotretinoin is approved by the US Food and Drug Administration for treating severe recalcitrant nodular acne but is often used to treat resistant or persistent moderate to severe acne, as well as acne that produces scarring or significant psychosocial distress.

Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice

Primary acne lesions are likely to improve weeks before PIH resolves and helping patients manage their expectations may reduce frustration, so combining retinoids with other topical agents and procedures such as superficial chemical peels can help to improve hyperpigmentation.

Updates in the understanding and treatments of skin & hair disorders in women of color☆☆☆

Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series

A case series supports the favorable efficacy and safety of facial and truncal AV treatment with trifarotene 0.005% cream, with or without oral doxycycline, in subjects with SoC (phototypes III–VI).

Take specific considerations into account when treating acne in patients with skin of colour

The early promise shown by lasers and phototherapies as adjunctive therapy for acne requires validation, especially in patients with skin of colour.

Issues of therapy for post-acne post-inflammatory hyperpigmentation

The use of innovative dermocosmetic products containing salicylic acid and licochalcon A effectively reduces post-acne pigmentation.

Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review

Current evidence on the safety and efficacy of acne treatments during pregnancy and breastfeeding is summarized to aid patient-physician decision-making on acne management in special populations.

The New Face of Preadolescent and Adolescent Acne: Beyond the Guidelines.

This roundtable report describes 5 focus areas of acne pathophysiology, specifically the role of hormones; psychological aspects of acne; management of acne in younger patients; acne in skin of color; and evaluation of clinical success, with the aim of empowering primary care physicians to refine the care they provide for patients with acne.



Acne in skin of color: Practical approaches to treatment

Early and efficacious treatment of acne in skin of color patients may minimize pigmentary abnormalities and keloid scarring, and treatment regimens may be tailored to ensure favorable outcomes for patients of all skin types.

A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies.

Although the medical and surgical treatment options are the same, it is the sequelae of the disease that are the distinguishing characteristics of acne in skin of color, namely postinflammatory hyperpigmentation and keloidal or hypertrophic scarring.

Acne vulgaris in skin of color.

This article reviews data derived from a survey of skin of color patients with acne vulgaris seen at the Skin of Color Center, Department of Dermatology, St. Luke's-Roosevelt Hospital, in New York City, to help clinicians in their diagnosis and treatment of acne vulgarIS.

The Asian Dermatologic Patient

  • S. HoH. Chan
  • Medicine
    American journal of clinical dermatology
  • 2009
The Asian patient with Fitzpatrick skin types III–V is rarely highlighted in publications on cutaneous disorders or cutaneous laser surgery. However, with changing demographics, Asians will become an

Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.

The treatment of postinflammatory hyperpigmentation should be started early to help hasten its resolution and begins with management of the initial inflammatory condition.

Guidelines for the Management of Acne Vulgaris in Adolescents

Over recent years dermatologists have increasingly used this drug to treat patients with moderate acne which has not responded to other systemic therapies, particularly when associated with scarring or significant psychological disability, but this use is outside the current license of the drug.

Efficacy and cutaneous safety of adapalene in black patients versus white patients with acne vulgaris.

Adapalene appears to be a viable treatment for black patients with acne vulgaris, a topical retinoid analog that has demonstrated efficacy in the reduction of noninflammatory and inflammatory lesions, along with excellent cutaneous tolerance.

Acne vulgaris

Utilizing combination therapy for ethnic skin.

There was a trend toward better resolution of hyperpigmentation in the subjects receiving the clindamycin-BPO topical gel in combination with RAM gel 0.04%, and the pigmentary changes in subjects of color with acne who were enrolled in a community-based trial comparing 3 different topical therapeutic regimens.